Spots Global Cancer Trial Database for A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
Official Title: A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.
Study ID: NCT00913198
Conditions
Interventions
Study Description
Brief Summary: The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinique d'Oncologie Médicale, Institut Jules Bordet, Brussels, , Belgium
Oslo University Hospital, The Norwegian Radium Hospital,, Oslo, , Norway
Oslo University Hospital, Ullevål, Oslo, , Norway
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
